Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of Asthma

Author:

Nilsson Magnus,Rhedin MagdalenaORCID,Hendrickx Ramon,Berglund Susanne,Piras Antonio,Blomgran ParmisORCID,Cavallin AndersORCID,Collins Mia,Dahl Göran,Dekkak Bilel,Ericsson Therese,Hagberg Niklas,Holmberg Ann Aurell,Leffler AgnesORCID,Lundqvist Anders J,Markou Thomais,Pinkerton James,Rönnblom LarsORCID,Siu Stacey,Taylor Vanessa,Wennberg TiiuORCID,Zervas DimitriosORCID,Laurence Arian D JORCID,Mitra Suman,Belvisi Maria GORCID,Birrell Mark,Borde Annika

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Reference64 articles.

1. Global Asthma Network. The global asthma report. Available from: http://www.globalasthmareport.org/. Accessed July 16, 2021.

2. Asthma

3. Global Initiative for Asthma. Global strategy for asthma management and prevention. Available from: https://ginasthma.org/reports/. Accessed July 16, 2021.

4. Asthma control, severity, and quality of life: Quantifying the effect of uncontrolled disease

5. Systematic literature review of the clinical, humanistic, and economic burden associated with asthma uncontrolled by GINA Steps 4 or 5 treatment

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3